Expression of erythropoietin in oxygen-induced retinopathy in mouse

Liying Sun,Kanxing Zhao,Li Yan
DOI: https://doi.org/10.3760/cma.j.issn.2095-0160.2008.08.009
2008-01-01
Abstract:Objective: Retinopathy of prematurity (ROP) is a neovasculariztion and fiber tissue proliferative disease caused by undeveloped retinal vessels. The purpose of this study was to investigate the expression variance and signification of erythropoietin (EPO) in oxygen-induced retinopathy in mouse. Methods: Fourteen one-week-old C57BL/6J mice were exposed to 75% oxygen for 5 days and to room air for another 5 days to establish the oxygen induced retinopathy model. Another fourteen mice were kept in room air as control group. The ADPase histochemieal technique was applicated for retinal flatmount to assess the oxygen-induced changes of retinal blood vessels. The proliferative neovascular response was quantified by counting the endothelial cell nuclei of new vessels breaking through retinal inner membrance in paraffin section. Immunocytochemistry was performed on some of cross-section of the retina to detect EPO protein expression, and integrated optical density (IOD) was determined with image analysis system. Results: Constriction and occlusion of the retinal blood vessels and decrease in central perfusion were found under the hyperoxia condition, and dilation and proliferation of blood vessels were found under the relatively hypoxia condition. The mean neovascular nucleus per cross-section was 20.2 ± 0.78 in oxygen exposure group and 0.30 ± 0.48 in the control group, showing a significant difference between them (t = -68.03, P < 0.001). The EPO IOD in oxygen exposure group and control group was 45.61 ± 0.59 and 24.91 ± 0.64, showing a higher level in oxygen exposure group (t = 30.89, P < 0.05). The results of immunocytochemistry showed parallel corresponding relation between expression of EPO and neovascularization. Conclusion: The expression changes of EPO protein at different time is coincident with the pathology of ROP, implying this cytokine may participate in retinal new vessel formation of ROP.
What problem does this paper attempt to address?